CSAM Health Group AS Stocks

NOK 0Last Updated 23.03.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

NOK 71.68M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
NOK 0
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

CSAM Health Group AS provides various ehealth solutions in Norway and internationally. The company offers CSAM Arcidis, an integrated system for teleradiology; CSAM DICOM Server for handling radiology data; CSAM HelseMail for transfer of confidential patient data between healthcare organizations; CSAM Infobroker, a vendor-neutral telemedicine system for radiology that enables multiple clinicians to share resources and knowledge; CSAM S7, a platform for self-care and health counselling; CSAM Web Client, a web-based user interface and connectivity solution that allows users to access multiple CSAM applications and functions; and CSAM XDS, a central archive for storing and managing various types of clinical patient data. It also provides CSAM Cardio, an ECG and diagnostic storage tool; CSAM CIMA, a mobile application for capturing, using, and sending medical media; CSAM Media, a web-based medical imaging solution; CSAM Medimaker for image management and workflow solution; CSAM Picsara, an image management solution; and CSAM TRIS, a radiology information system. In addition, the company offers CSAM Partus, a maternity information system; CSAM Natus, a maternity care system; CSAM iPana Labor Information System, a web-based labour information system; CSAM iPana Maternity, a cloud-based service platform that enables expectant mothers, hospitals, and maternity clinics to electronically collect, store, and share medical information; and CSAM Fertsoft, a care and practice management software. Further, it provides CSAM Optima Predict solution for operational planning; CSAM Optima Live; CSAM AMIS, an emergency medical information system; CSAM IMTS, a tool for assessing and prioritizing patients; CSAM Paratus, an emergency response system; CSAM CoordCom; CSAM ResQMobile; CSAM Cytodose, an oncology management solution; and CSAM ProSang, an advanced laboratory information management system. The company was founded in 1999 and is headquartered in Oslo, Norway.

Company Valuation

Slightly undervalued
5/7

Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. Specifically, the stock is fairly valued on P/E. Editor's note:

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks